Technology News

Technology stock news including AI, semiconductors, cloud computing, and software. Coverage of Big Tech earnings, product launches, and sector trends.

Snap Rallies 8.6% on Tech Bounce, but AR Glasses and Ad Weakness Loom
Technology Sarah Chen

Snap Rallies 8.6% on Tech Bounce, but AR Glasses and Ad Weakness Loom

Snap surged 8.56% to $5.71 as tech stocks rallied, ending a six-day slide. Shares remain 45% below their 52-week high, with investors eyeing the Specs AR glasses debut and upcoming quarterly results.

SNAP
D-Wave Quantum Stock Surges on Mizuho Price Target Boost
Technology Sarah Chen

D-Wave Quantum Stock Surges on Mizuho Price Target Boost

D-Wave Quantum shares rose 12.6% to $26.26 after Mizuho raised its price target to $35, citing quantum roadmap progress and surging bookings, despite weak revenue and widening losses.

QBTS QUBT RGTI IONQ
Beam Global Surges on European Patent, but Q1 Woes Linger
Technology Sarah Chen

Beam Global Surges on European Patent, but Q1 Woes Linger

BEEM surged 28% premarket on a new European patent for battery thermal management, but the company must convert its $9M backlog into Q2 revenue to offset a 51% Q1 revenue drop.

BEEM
QTREX Quantum Stock Soars on 97% AME Yield Milestone, Eyes Commercial Production
Technology Sarah Chen

QTREX Quantum Stock Soars on 97% AME Yield Milestone, Eyes Commercial Production

QTREX Quantum shares surged 70.54% after AME system achieved 97% yield validation at a major U.S. interconnect manufacturer, signaling commercial readiness.

QTRX
Marvell Surges on AI Demand, Analyst Upgrade, and S&P 500 Inclusion
Technology Sarah Chen

Marvell Surges on AI Demand, Analyst Upgrade, and S&P 500 Inclusion

Marvell Technology shares surged 10.43% to $308.88, driven by AI demand, a price target hike to $350 from GF Securities, and its upcoming addition to the S&P 500.

MRVL
Iveda Solutions Surges on RTLS Upgrade; Nasdaq Compliance Looms
Technology Sarah Chen

Iveda Solutions Surges on RTLS Upgrade; Nasdaq Compliance Looms

Iveda Solutions shares jumped 12.57% to $0.3162 on Monday after unveiling a higher-precision RTLS upgrade. The stock remains speculative, with losses and a Nasdaq compliance deadline ahead.

IVDA
Joby Aviation Shares Surge on Strong Air Taxi Demand Data
Technology Sarah Chen

Joby Aviation Shares Surge on Strong Air Taxi Demand Data

Joby Aviation shares climbed 7% to $9.67 following a survey showing 79% consumer interest in air taxis, with FAA certification and Dubai service as key catalysts.

JOBY
Substack Expands into Brand Sponsorships, Hires Ex-Roku Executive
Technology Sarah Chen

Substack Expands into Brand Sponsorships, Hires Ex-Roku Executive

Substack hires Dan Robbins as first head of brand sponsorships, with Uber, T-Mobile, Balenciaga, and Yahoo Scout investing millions in creator deals, marking a shift from subscription-only revenue.

UBER
Super Micro Shares Stabilize After $3.68B Convertible Offering
Technology Sarah Chen

Super Micro Shares Stabilize After $3.68B Convertible Offering

Super Micro Computer shares steadied at $30.85 after a $3.68 billion convertible preferred offering. Investors now await fiscal Q4 results to assess AI order conversion and margin strength.

SMCI
Western Digital Shares Surge on Morgan Stanley Upgrade, AI Storage Demand
Technology Sarah Chen

Western Digital Shares Surge on Morgan Stanley Upgrade, AI Storage Demand

Western Digital shares surged 16% after Morgan Stanley lifted its price target to $650, citing strong nearline enterprise storage demand and AI-driven HDD pricing power.

WDC
Nvidia's $25B Bond Sale Fuels Share Rally as AI Demand Stays Strong
Technology Sarah Chen

Nvidia's $25B Bond Sale Fuels Share Rally as AI Demand Stays Strong

Nvidia shares jumped 3.5% after a $25 billion bond sale, upsized from $20 billion due to $85 billion investor demand, signaling strong credit confidence ahead of August 26 earnings.

NVDA SPY
Intellia Therapeutics Surges 23% on Promising Phase 3 Data for CRISPR Therapy
Technology Sarah Chen

Intellia Therapeutics Surges 23% on Promising Phase 3 Data for CRISPR Therapy

Intellia Therapeutics shares surged 23% to $14.92 after Phase 3 data showed lonvo-z reduced hereditary angioedema attacks by up to 91% versus placebo, with FDA filing as the next catalyst.

NTLA